• Y D Bildaci, H Bulut, O C Elcioglu, M Gursu, and R Kazancioglu.
• Haydarpaşa Numune Training and Research Hospital Division of Nephrology, University of Health Sciences Turkey, Uskudar, Istanbul, Turkey.
• Niger J Clin Pract. 2022 Sep 1; 25 (9): 1452-1456.

BackgroundDiabetes mellitus is the most well-known and common cause of end-stage renal disease. Excessive inflammatory processes were hypothesized to be one of the reasons for progression to end-stage disease. Even though progression to end stage disease tried to be prevented with some dietary measures such as lowering nitrogen in diet, none of the methods tried were successful enough.AimsIn our study, we aimed to determine the effects of alfa keto analog use in altering levels of inflammatory markers when added to dietary program in a diabetic rat model.Patients And MethodsThe study was performed on 22 male Sprague Dawley rats with streptozocine induced diabetic nephropathy. Both groups were fed with low protein diet except for study group with added alfa keto analogs. Biochemical values and inflammatory markers were studied with ELISA assay.ResultsSignificant difference in serum albumin was found between study group and control group following administration of alfa keto analogs (p <.001). Also mentioned dietary modification made a significant difference in suppression of inflammatory reactions for interleukin (IL)-1, IL-6, IL-10, IL-18 and tumor necrosis factor-α.ConclusionAdding keto amino acids to diets that are already low on protein, can slow progression to end-stage renal disease by reducing inflammation and protein loss in an animal model.

22 keywords...

hide…